Pharmaceutical composition comprising thrombolytic peptide-tetrahydroisoquinoline conjugate
US-12059448-B2 · Aug 13, 2024 · US
Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
US9533054B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9533054-B2 |
| Application number | US-201414203596-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2014 |
| Priority date | Mar 11, 2013 |
| Publication date | Jan 3, 2017 |
| Grant date | Jan 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides novel amphiphilic drug-drug conjugates useful as cancer therapeutics, and compositions and methods thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. An amphiphilic compound having the structural formula: 2. An amphiphilic compound having the structural formula: 3. An amphiphilic compound having the structural formula: 4. An amphiphilic compound having the structural formula: 5. An amphiphilic compound having the structural formula:
Assignees
Inventors
Classifications
Sugars, nucleosides, nucleotides or nucleic acids · CPC title
- A61K47/55Primary
the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug · CPC title
the form being a nanoparticle, e.g. an immuno-nanoparticle · CPC title
having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid · CPC title
with ribosyl as the saccharide radical · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9533054B2 cover?
- The invention provides novel amphiphilic drug-drug conjugates useful as cancer therapeutics, and compositions and methods thereof.
- Who is the assignee on this patent?
- Univ Shanghai Jiaotong
- What technology area does this patent fall under?
- Primary CPC classification A61K47/55. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).